Virtual Reality in End Stage Kidney Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Social Virtual Reality, Individual Virtual Reality.
- Who it may be relevant to
- Registry conditions: End Stage Kidney Disease. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Social Virtual Reality to Alleviate Loneliness and Symptoms for Individuals Receiving Hemodialysis
Overview
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Detailed description
In a single site, 2-arm (Social Virtual Reality group; Individual Virtual Reality Group), parallel, randomized controlled trial we will enroll 60 subjects (n=30 per group) to assess the effects of Social Virtual Reality to Individual Virtual Reality on symptoms in participants with end stage kidney disease who are receiving hemodialysis.
To compare the effects of social virtual reality to individual virtual reality on loneliness To explore the effects of social virtual reality to individual virtual reality on anxiety and depression.
To compare the effects social virtual reality to individual virtual reality on quality of life.
Interventions
- Behavioral Social Virtual Reality
Participants interact using virtual reality during dialysis. - Behavioral Individual Virtual Reality
Participants use virtual reality alone during dialysis.
Primary outcome measures
- De Jong Gierveld Scale [Time frame: Baseline and 4 Weeks]
Eligibility criteria
Inclusion criteria
- Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month
Exclusion criteria
- Acutely ill
- Active nausea
- Epilepsy
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- University of Pennsylvania — Philadelphia
Identifiers
NCT: NCT06356168 · SVR/IVR